p.antonsen
Submits third-party assay reports on material purchased directly. Based in Tours.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
5
n=5
Annotations
0
n=0
Median purity submitted
98.40%
n=5
Suppliers covered
5
n=5
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043086 | Ipamorelin | KP | KP-2606-D5887 | PeptideMeter | 2026-Q3 | 98.74 | 3.45 | 91.6 | Supplier-supplied | 1 | FAIL |
| AX-2026-041576 | CJC-1295 with DAC | QSC | QSC-2512-G6894 | VendorInvestigate | 2026-Q1 | 98.22 | 2.23 | 101.0 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043559 | MOTS-c | BCH | BCH-2601-U7218 | Janoshik | 2026-Q1 | 98.40 | 5.76 | 93.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019582 | GHRP-6 | Homopeptide | HOMO-2508-W1724 | Janoshik | 2025-Q4 | 99.93 | 6.25 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005214 | SS-31 (Elamipretide) | SSA | SSA-2408-G7000 | Kestrel | 2024-Q3 | 97.51 | 6.55 | 93.4 | Supplier-supplied | 1 | FAIL |
| Supplier | Records | Median purity |
|---|---|---|
| KP | 1 | n<3 |
| QSC | 1 | n<3 |
| BCH | 1 | n<3 |
| Homopeptide | 1 | n<3 |
| SSA | 1 | n<3 |